OOIR: Observatory of International Research

Papers

(The median citation count of Allergy and Asthma Proceedings is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination	66
Association of EDN levels in patients with asthma and correlation with FEV₁%: A meta-analysis	56
COVID-19: A continuing challenge for the allergist/immunologist	35
Biomarker underuse contributes to an inability to phenotype patients with severe uncontrolled asthma	28
Not all marketed skin cleansers’ pH is optimal for atopic dermatitis	27
Future directions in allergen immunotherapy	27
Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study	24
Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema	23
The role of component-resolved diagnosis in Hymenoptera venom allergy in clinical practice	23
Meteorological and environmental factors that impact pollen counts, allergenicity, and thresholds: A scoping review	20
Venom allergen immunotherapy	20
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol	18
Predictors of anaphylaxis to peanut and tree nuts in a Mediterranean population	18
SARS-CoV-2 infection and the human immune system: A continuing journey of discovery	18
Safety of ciclesonide in children with asthma: A review of randomized controlled trials	18
For the Patient	18
For the Patient	18
Total IgE as a biomarker of omalizumab response in chronic spontaneous urticaria: A meta-analysis	17
Caregiver perceptions and attitudes associated with oral immunotherapy on social media	16
Symptom flares after COVID-19 infection versus vaccination among youth with PANS/PANDAS	16
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2	16
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist	16
Impact of steroids on the immune profiles of children with asthma living in the inner-city	16
Prevalence of neurological diseases among patients with selective IgA deficiency	15
Efficacy and safety of sublingual allergen immunotherapy	15

The diagnostic accuracy of spirometry versus peak expiratory flow test for follow-up of adult asthma patients at primary care level	15
Cost assessment of allergy procedures to improve high-value care implementation	15
Cold-induced urticaria in children: A multicenter, retrospective cohort study	14
Health disparities in hymenoptera venom allergy management	14
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization	14
Evaluation of nasal symptoms to distinguish eosinophilic from noneosinophilic nasal polyps based on peripheral blood	13
The association of timothy grass allergy and cat ownership on cat sensitization	13
Patients' and physicians' attitudes and perception about asthma in the Gulf: A subset analysis from the Asthma Insights and Management Survey in the Gulf and Russia	12
Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber	12
Assessing the cost and quality-of-life impact of on-demand‐only medications for adults with hereditary angioedema	12
COVID-19 in Italian children and adolescents: The role of allergy and asthma	12
Food protein‐induced enterocolitis syndrome: Current practices in oral food challenge	12
Immunodeficiency: Overview of primary immune regulatory disorders (PIRDs)	12
Long-term efficacy and safety of omalizumab in patients with allergic asthma: A real-life study	11
Shifts in allergy practice in a COVID-19 world: Implications of pre‐COVID-19 national health care provider and patient surveys of treatments for nasal allergies	11
Impact of COVID-19 measures on exacerbation rates and healthcare visits in US asthma patients	11
A combined risk modeling strategy for clinical prediction of beta-lactam allergies in children	11
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis	10
How important is patch testing with dental materials in real-life clinical practice?	10
Operationalizing shared decision making in clinical practice	10
Do commercial dog extracts cross-react with Felis domesticus allergen 1	10
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being	9
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study	9
Exploring the spectrum of allergic disorders that continue to challenge the Allergist-Immunologist: From hereditary angioedema to metal implant allergy	9
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks	9
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children	9
Analysis of the long-term efficacy and safety of subcutaneous immunotherapy for atopic dermatitis	9
Longitudinal experience with treatment of acquired angioedema using tranexamic acid	9
Idiopathic non-mast cell angioedema: Treatment insights from global experts	9
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 2022	8
Sustained decrease in pediatric asthma emergency visits during the first year of the COVID-19 pandemic	8
For the patient	8
For the Patient	8
The influence of sea breeze on mold spore dispersion	8
Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22‐23, 2022, Portsmouth, NH	8
Integrating innovation and shared decision-making in allergy and immunology practice	8
Association between elevated serum triglycerides and asthma in patients with obesity: An explorative study	8
TEV/FEV₃ as a coherent metric of small airway dysfunction in childhood asthma	8
Female sex as a risk factor for penicillin drug allergy in the inpatient setting	8
For the Patient	8
Management and referral patterns for new-onset chronic cough in primary care patients	8
Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience	7
For the Patient	7
Current and emerging therapies for eosinophilic esophagitis	7
Allergic diseases in children: A continuing challenge for the Allergist-Immunologist	7
Evaluation and management of chronic cough in adults	7
For the Patient	7
For the patient	7
Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19	7
Evaluation and management of adverse reactions to the COVID-2019 vaccines	7

COVID-19 pandemic impact on telehealth use and perceptions for atopic and respiratory disease: Survey results	7
COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptance	7
Outcomes among patients with COVID-19 and asthma: A systematic review and meta-analysis	7
Assessing cross-reactivity in allergen immunotherapy	6
Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma	6
Long-term adherence strategies for allergen immunotherapy	6
Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy	6
Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis	6
How important is proper dosing for subcutaneous and sublingual allergy immunotherapy?	6
A trajectory of the FDA approval of the first vaccine targeting RSV: A greek tragedy with a happy ending	6
Curcumin does not significantly affect immediate skin tests	6
Can clinical characteristics differentiate patients with unexplained chronic cough from patients with asthma and COPD?	6
Abstracts presented at the Western Society of Allergy, Asthma & Immunology, Annual Scientific Session, February 6-10, 2022, Maui, Hawaii	6
For the Patient	6
Does vitamin D deficiency in asthma affect clinical and functional parameters? A Turkish multicenter study	6
Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study	6
Navigating the uncharted waters of chronic urticaria: A perplexing challenge for the allergist-immunologist	6
Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome	5
Clinical phenotypes of childhood food allergies based on immune mechanisms: A multicenter study	5
Bronchial provocation test measured by using the forced oscillation technique to assess airway responsiveness	5
Clinical features, severity, and immunological changes during venom immunotherapy in children and adults	5
Eosinophilic esophagitis in children: Updates and practical aspects of management for allergists in a non‐tertiary care private practice setup	5
Standardized allergen extracts for allergen immunotherapy	5
Outcomes of eosinophilic esophagitis in patients managed in a multidisciplinary clinic	5
Inpatient allergy delabeling of pediatric patients with low-risk penicillin allergy status through direct oral amoxicillin challenge	5
2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis	5
For the Patient	5
The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience	5
Salivary microRNAs in pediatric eosinophilic esophagitis	5
Dupilumab rapidly improves eustachian tube dysfunction and otologic symptoms in aspirin-exacerbated respiratory disease	5
Weighing the benefits and risks of oral immunotherapy in clinical practice	5
Integrating the evidence in allergen immunotherapy: Why real-world data should be important for the practicing clinician?	5
Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort	5
Atopic dermatitis: Best of guidelines and yardstick	5
The need for continuous quality assessment for providing optimal comprehensive care for patients with alpha-1 antitrypsin deficiency	5
Etiology and predictors of cluster attacks of hereditary angioedema that recur despite pharmaceutical treatment	5
Short-term prophylaxis for children and adolescents with hereditary angioedema	5
Ideal body position for epinephrine autoinjector administration	5
Abstracts presented at the Eastern Allergy Conference May 30‐June 2, 2024, Palm Beach, Florida	5
Pearls and pitfalls in food protein-induced enterocolitis syndrome (FPIES)	5
Psychiatric comorbidity and quality of life in patients with drug hypersensitivity	4
A 48-year-old female with perioperative anaphylaxis	4
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center	4
A systematic review and meta-analysis exploring the bidirectional association between asthma and gastroesophageal reflux disease in children	4
The relationship between childhood atopic dermatitis and asthma in an under resourced community	4
Immunodeficiency: Complement disorders	4
Monkeypox viral infection and disease: A challenge for the allergist-immunologist	4
Eosinophilic esophagitis: from discovery to effective treatment	4
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes	4
Healthcare utilization of patients with hereditary angioedema treated with lanadelumab and subcutaneous C1-inhibitor concentrate	4
Removing penicillin allergy label in a hospitalized adolescent with a remote penicillin and recent cephalosporin allergy	4
Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management	4
Mast cell activation syndrome: Myths and realities	4
Evaluation of drug patch tests in children	4
Impact of socioeconomic factors and house cleaning on asthma control in women	4
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis	4
Long-term prophylaxis in hereditary angioedema management: Current practices in France and unmet needs	4
An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapy	4
Comparison of clinical traits for seasonal and perennial allergic rhinitis during allergen exposure	4
Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity	4
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan	4
Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department	4
Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis	4
Isotype deficiencies (IgG subclass and selective IgA, IgM, IgE deficiencies)	3
Recurrent and acute abdominal pain as the main clinical manifestation in patients with hereditary angioedema	3
Relationships between bronchiectasis and time to achieving target trough immunoglobulin G levels in patients with common variable immunodeficiency	3
Abstracts presented at the Eastern Allergy Conference June 1‐4, 2023, Palm Beach, Florida	3
Assessment of mask use on oxygen saturation in adults and children with asthma	3
Real world use of peanut component testing among children in the Chicago metropolitan area	3
Common but neglected problem in chronic spontaneous urticaria: Sleep disturbance	3
Health-care resource utilization associated with peanut allergy management under allergen avoidance among commercially insured individuals	3
Abstracts presented at the Eastern Allergy Conference, June 3‐6, 2021, Palm Beach, Florida	3
The relationship of D. pteronyssinus allergic component sIgE and sIgG₄ in house dust mite allergic rhinitis or/and allergic asthma patients	3
Delayed systemic urticarial reactions following mRNA COVID-19 vaccination	3
Understanding of lipid transfer protein sensitization patterns and its clinical significance in children	3
Allergen immunotherapy and shared decision-making	3
Comparison of commercial allergen extract with various milk products of skin prick tests in diagnosing cow's milk protein allergy	3
Efficacy and safety of hymenoptera venom immunotherapy	3
The relationship between mast cell activation syndrome, postural tachycardia syndrome, and Ehlers-Danlos syndrome	3
A case-control study for comorbidity and laboratory factors associated with food-induced anaphylaxis	3

Population-based incidence of food allergies in Olmsted County over 17 years	3
Allergy immunotherapy for allergic fungal respiratory diseases	3
Response:	3
The return of the mixed respiratory bacterial vaccine	3
Intralymphatic immunotherapy for allergic rhinitis: A systematic review and meta-analysis	3
Essentials of allergen immunotherapy: A primer for the practitioner	3
Long-term oral administration of transgenic rice containing cedar pollen T-cell epitopes potentially improves medication- and allergy-related quality-of-life scores	3
Treatment strategies for postviral olfactory dysfunction: A systematic review	3
Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitis	3
Assessment of clinical phenotypic characteristics of patients with angioedema without wheals in a turkish population	3
Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic	3
Prevalence and bidirectional association between rhinitis and urticaria: A systematic review and meta-analysis	3
Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines	3
COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications	3
The PANDAS/PANS disorders. Is it time for more allergist-immunologists to get involved?	3
Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT)	3
Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose	2
For the patient	2
Exploring mast cell disorders: Tryptases, hereditary alpha-tryptasemia, and MCAS treatment approaches	2
Abstracts presented at the Eastern Allergy Conference, June 2‐5, 2022, Palm Beach, Florida	2
The immunologic response to severe acute respiratory syndrome coronavirus 2	2
Effects of mechanical washing and drying on the removal of pet allergens	2
Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs	2
For the Patient	2
A 33-year-old man with a history of recurrent pneumonia presenting with hypoxemic respiratory failure	2
Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes	2
A masquerade of recurrent anaphylaxis	2
The utility of shared decision making in the management of hereditary angioedema	2
A 62-year-old man with new-onset bullae	2
Association of serotonin reuptake inhibitors with asthma control	2
The complexities of allergic diseases continue to challenge the allergist-immunologist	2
Current concepts in optimized construction of allergen immunotherapy vaccines: Practical implications	2
For the patient	2
Systematic review of omalizumab for refractory clonal and non-clonal mast cell activation syndrome	2
Emergency department revisits and rehospitalizations among infants and toddlers for acute allergic reactions	2
New insights in the optimal diagnosis and management of food allergy	2
Immunodeficiency: Quantitative and qualitative phagocytic cell defects	2
Evaluation of the peripheral blood eosinophil count as a predictor for fractional exhaled nitric oxide or bronchodilator reversibility test outcome	2
Efficacy of parenteral bronchodilators on ventilatory outcomes in pediatric critical asthma: a national cohort study	2
An 82-year-old man with new skin lesions after COVID-19 vaccination	2
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course	2
The safety of initial single therapeutic dose challenge with a 5-day prolonged drug provocation test in children with a history of low-risk non-immediate reactions to beta-lactam antibiotics	2
Immunoglobulin therapy for immunodeficiency	2
United States Pharmacopeia guidance for compounding of allergenic extracts for allergen immunotherapy	2
For the Patient	2
Profiles of sensitization and comorbidity in asthma patients with markedly increased serum total IgE (>1000kU/L)	2
Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease	2
For the patient	2
Accelerated/rush allergen immunotherapy	2
Evaluation of allergic diseases in children diagnosed with cutaneous mastocytosis	2
Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease	2
Evaluation of the ocular safety associated with the exhalation delivery system with fluticasone	2
Asthma biomarkers and COVID-19 continue to dominate current medical issues	2
Peanut allergy in an adult following cardiac transplant from a non-atopic donor	2
How satisfactory is on-demand icatibant from the patients' perspective in real life?	2
Considering different Montreal Cognitive Assessment cutoff scores for older adults with asthma	2
Immunodeficiency: Burden of Illness	2
Validation of a questionnaire assessing smell loss in an international aspirin-exacerbated respiratory disease population	2
Efficacy and safety of an e-consult program for COVID-19 vaccine allergy concerns	2